Sort
130,381 grants matching “hiv”
Immune Correlates of Protection from TB
$828,491Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
$828,484Neel Rajnikant Gandhi · Albert Einstein College Of Medicine · R01 · FY2010 · AI
The effect of HIV exposure and infection on immunity to TB in children
$828,368Grace C John-Stewart · University Of Washington · R01 · FY2019 · AI
Core--Animal model
$828,261Thomas W North · J. David Gladstone Institutes · P01 · FY2008 · AI
Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design
$828,199Katie Brooks Biello · Brown University · R01 · FY2021 · NR
RAI CONDOM: Feasibility & Acceptability Study, Phase 1 Pilot Clinical Research
$828,188Daniel Resnic · Strata Various · R43 · FY2009 · AI
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
$828,185Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI
Human Mitochondrial Dna Polymerase With Anti-hiv Nucleotides
$828,162William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users
$828,153Sherry Deren · New York University · P30 · FY2011 · DA
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
$828,127John Koethe · Vanderbilt University Medical Center · R01 · FY2019 · DK
Evaluating Demand Generation (Stylish Man) for HIV/Family Planning Services Rakai
$828,091Maria J Wawer · Johns Hopkins University · R01 · FY2014 · AI
Immune based interventions for HIV eradication
$828,064Mirko Paiardini · Emory University · R01 · FY2018 · AI
Analytical Resources Core
$828,045Nathan A Vandergrift · Duke University · P01 · FY2017 · AI
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
$827,942Luis J. Montaner · Wistar Institute · R01 · FY2019 · DA
STRUCTURES OF HIV REVERSE TRANSCRIPTASE WITH SUBSTRATES
$827,930Edward V Arnold · Rutgers, The State Univ Of N.J. · R37 · FY2007 · AI
Antibody Responses in Aging SIV Infected Monkeys
$827,888Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2015 · AI
B cell determinants of EBV latency
$827,799Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · CA
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$827,788Charles T Roberts · Oregon Health & Science University · R01 · FY2020 · DK
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)
$827,750Steven A Safren · University Of Miami Coral Gables · P30 · FY2019 · MH
Early Events in Mucosal SIV Pathogenesis
$827,743Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2009 · AI
AIDS International Training and Research Program (AITRP)
$827,717Christopher C. Whalen · Case Western Reserve University · D43 · FY2007 · TW
Efficacy of a community-based PrEP uptake intervention for people who inject drugs in the US Northeast
$827,701Katie Brooks Biello · Brown University · R01 · FY2020 · DA
Routes to Enhanced HIV Neuropathogenesis Through Expression of Subclinical Levels of Endogenous Amyloid-Beta
$827,685David J Volsky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
Impact of smoking and its cessation on systemic and airway immune activation
$827,665Nina H. Lin · Boston Medical Center · R01 · FY2016 · DA
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV
$827,657Priscilla Y. Hsue · University Of California, San Francisco · R56 · FY2014 · HL